Invitrogen™ Human BCAS4 Synthetic Peptide

Ref.: BL-RE-175823Manufacturer ref.: PEP-1021 50 μg
€149.00 excl. VAT

BCAS4 Synthetic Peptide, PEP-1021, from Invitrogen.

Gene ID (Enter)
55653
Species
Human
Purification method
Purified
Accession number
Q8TDM0
Common name
Human BCAS4
Brand
Invitrogen

BCAS4 Synthetic Peptide, PEP-1021, from Invitrogen.

BCAS4 Synthetic Peptide, PEP-1021, from Invitrogen.

The Breast carcinoma amplified sequence (BCAS4) gene is localized to 20q13, a region that is often amplified in breast cancers. It was isolated by the cloning of a highly overexpressed 1.3 kb transcript from the fusion of the last two exons of the BCAS3 and BCAS4 genes. This BCAS3-BCAS4 fusion transcript is only found in the MCF7 cell line, but the BCAS4 gene is also overexpressed in nine of thirteen breast cancer cell lines. The role of BCAS4 is unknown but its mRNA is highly expressed in thymus, spleen, kidney, brain, and placenta, suggesting BCAS4 plays other roles in multiple tissues.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15275019
Specifications
Gene ID (Enter)55653
SpeciesHuman
Purification methodPurified
Accession numberQ8TDM0
Common nameHuman BCAS4
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)BCAS4
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1021
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.